However, most CD133+ cells had high tumorigenicity and invasion characteristics (18) and therefore, CD133+ expressing glioblastoma cells were considered as the observation subject with the aim of further developing the scope and depth of understanding of glioma stem cell research. The gene discussed is PROM1; the disease is glioblastoma.